z-logo
open-access-imgOpen Access
Clostridium butyricum inhibits the progression of colorectal cancer and alleviates intestinal inflammation via the myeloid differentiation factor 88 (MyD88)-nuclear factor-kappa B (NF-κB) signaling pathway
Author(s) -
Mingyao Zhou,
Wei Yuan,
Bing Yang,
Wei Pei,
Jie Ma,
Qiang Feng
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-1670
Subject(s) - azoxymethane , clostridium butyricum , tunel assay , microbiology and biotechnology , terminal deoxynucleotidyl transferase , apoptosis , chemistry , cancer research , biology , colorectal cancer , cancer , medicine , biochemistry , fermentation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom